Furosemide for Accelerated Recovery of Blood Pressure Postpartum

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 384 participants.

Also called NCT03556761

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 384 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03556761
Other papers using this trial's data
  • Furosemide for Accelerated Recovery of Blood Pressure Postpartum in women with a hypertensive disorder of pregnancy: A Randomized Controlled Trial Hypertension (Dallas, Tex. : 1979), 2021-05-05 DOI, PubMed 33550824, PMC8099047 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03556761. Randomized; quadruple masking; primary purpose prevention. Start 2018-06-20 (actual); primary completion 2019-12-04 (actual). Results posted on 2020-09-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Furosemide for Accelerated Recovery of Blood Pressure Postpartum
Acronym
ForBP
Condition
Hypertension, Pregnancy-Induced
Intervention (Drug)
Oral furosemide
Intervention (Drug)
Placebo Oral Tablet
Lead sponsor
University of Pennsylvania (class: other)

Record details

Record id
cardio:ct-nct03556761
Content hash
aa113baa3b41576e763db61cdf17c14bf423e9c10b03ac138b5a24dc55c1f6cd